AI Article Synopsis
- Medical oncology specialists are continuing their research for new treatments to enhance life expectancy and quality of life for patients, despite the ongoing impact of COVID-19 on global health and the economy.
- In 2021, immunotherapy has been proven effective, either alone or combined with other treatments, across various cancer types.
- The focus this year includes new therapeutic strategies in lung, breast, melanoma, gynecological, digestive, urological, and ENT cancers.
Article Abstract
Despite COVID-19 pandemic, which is still deeply affecting world economy and global health, medical oncology specialists keep pursuing their effort for the identification of new therapeutic options to improve patients' life expectancy and quality of life. 2021 confirms the immunotherapy efficacy, alone or in combination with other modalities, across several indications. This year, we are summarizing the new approaches in the following sectors: lung, breast, melanoma, gynecological, digestive, urological and ENT areas.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.53738/REVMED.2022.18.767.182 | DOI Listing |
Publication Analysis
Top Keywords
[2021 oncology
4
oncology update]
4
update] despite
4
despite covid-19
4
covid-19 pandemic
4
pandemic deeply
4
deeply economy
4
economy global
4
global health
4
health medical
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!